EUVIMEDEUVIMED entdecken
Fallbericht

Progressive macrocytic anaemia over 14 years leading to the diagnosis of VEXAS syndrome in a patient initially diagnosed with adult-onset Still’s disease

Kazuya Abe, Kentaro Takahashi iD, Ayako Matsuki, Yoshitaka Zaimoku, Takeshi Umibe

Modern Rheumatology Case Reports · 29.06.2026 · 10 (2)

DOI: 10.1093/mrcr/rxag067 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, online erschienen am 12.07.2026. Verfasst von Kazuya Abe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy and Rheumatology, Matsudo City General Hospital, Chiba, Japan. Hauptthemen laut MEDLINE: Anemia, Macrocytic, Genetic Diseases, X-Linked, Still's Disease, Adult-Onset, Ubiquitin-Activating Enzymes. Die Arbeit nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a recently recognised autoinflammatory disease caused by somatic mutations in UBA1. Its clinical features include recurrent fever, systemic inflammation affecting multiple organs, and progressive haematologic abnormalities such as macrocytic anaemia. Because these manifestations overlap with other autoinflammatory diseases, including adult-onset Still’s disease, the diagnosis can be challenging. In this case report, we describe a patient initially diagnosed with adult-onset Still’s disease who was ultimately found to have VEXAS syndrome 5 years later due to progressive macrocytic anaemia. The patient developed recurrent fever and skin rash but did not have macrocytic anaemia at onset. Over the subsequent 5 years, his mean corpuscular volume progressively increased. Bone marrow biopsy revealed no evidence of malignancy but showed vacuoles in myeloid and erythroid progenitor cells. Based on these findings, VEXAS syndrome was suspected, and UBA1 testing identified the pathogenic p.Met41Thr variant, thereby confirming the diagnosis. This case highlights that macrocytic anaemia may not be present in the early phase of VEXAS syndrome. In patients diagnosed with adult-onset Still’s disease who later develop or progressively worsen macrocytic anaemia, clinicians should consider VEXAS syndrome and perform UBA1 variant testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, MacrocyticGenetic Diseases, X-LinkedStill's Disease, Adult-OnsetUbiquitin-Activating EnzymesMyelodysplastic SyndromesSkin DiseasesAdultHumansMaleBone MarrowDisease ProgressionMutationSkin Diseases, Genetic

Stichwörter der Autor:innen

UBA1VEXAS syndromeadult-onset Still’s diseasemacrocytic anaemiatocilizumab

Substanzen

UBA1 protein, humanUbiquitin-Activating Enzymes

Autor:innen und Institutionen

  • Department of Allergy and Rheumatology, Matsudo City General Hospital, Chiba, Japan.
  • Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan.
  • Innovative Clinical Research Center, Kanazawa University Hospital, Kanazawa, Japan.

ORCID-Profile: Kentaro Takahashi

Zitieren

APA

Abe, K., Takahashi, K., Matsuki, A., Zaimoku, Y., & Umibe, T. (2026). Progressive macrocytic anaemia over 14 years leading to the diagnosis of VEXAS syndrome in a patient initially diagnosed with adult-onset Still’s disease. Modern Rheumatology Case Reports, 10(2). https://doi.org/10.1093/mrcr/rxag067

Vancouver

Abe K, Takahashi K, Matsuki A, Zaimoku Y, Umibe T. Progressive macrocytic anaemia over 14 years leading to the diagnosis of VEXAS syndrome in a patient initially diagnosed with adult-onset Still’s disease. Modern Rheumatology Case Reports. 2026;10(2). doi:10.1093/mrcr/rxag067

BibTeX
@article{Abe2026,
  author = {Abe, Kazuya and Takahashi, Kentaro and Matsuki, Ayako and Zaimoku, Yoshitaka and Umibe, Takeshi},
  title = {Progressive macrocytic anaemia over 14 years leading to the diagnosis of VEXAS syndrome in a patient initially diagnosed with adult-onset Still’s disease},
  journal = {Modern Rheumatology Case Reports},
  year = {2026},
  volume = {10},
  number = {2},
  doi = {10.1093/mrcr/rxag067}
}
Kostenlos starten →